Controversy exists regarding the potential regenerative influences of incretin therapy on pancreatic beta-cells versus possible adverse pancreatic proliferative effects. Examination of pancreata from age-matched organ donors with type 2 diabetes mellitus (DM) treated by incretin therapy (